All News

The withdrawal of the FDA accelerated approval for locally advanced or metastatic urothelial carcinoma, a type of bladder cancer, does not affect other indications of the therapy.

Results from the RAMP 201 clinical trial are promising for patients with recurrent low-grade serous ovarian cancer.

The rate at which PSA rises after hormonal therapy for prostate cancer is a key factor in determining the effectiveness of the treatment.

Whenever I get sick, I experience a few side effects that usually go away, but unexplained weight loss becomes a problem for me.

For patients with cancer, Symproic may prevent constipation and improve quality of life.

An expert discussed the importance of patients learning about their specific type of breast cancer to understand potential treatment options.

A colleague and a patient with cancer each submitted nominating essays about an oncology nurse who made an impact in their lives.

Patients with a head and neck cancer subtype did not show differences in survival outcomes when treated with radiation versus transoral robotic surgery.

An expert discussed how the understanding of resistance mechanisms can help care teams develop a global treatment strategy for EGFR-mutated non-small cell lung cancer.

The FDA has approved Vyloy for patients with HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma with CLDN18.2-positive tumors.

As someone who disliked pink for years, it has grown on me over time, especially after having breast cancer.

From “Boy Meets World” actress Danielle Fishel discussing her breast cancer surgery to a young TikTok star dying from a rare liver cancer, here’s what’s happening in the cancer space this week.

In this on-demand webinar series, CURE partnered with SHARE Cancer Support to learn more about other challenges of breast cancer outside of treatment.

In this on-demand webinar series, CURE partnered with SHARE Cancer Support to learn more about emotional well-being as a patient and survivor of breast cancer.

Aspirin did not impact CVD incidence; however, risk may be higher in those with metastatic, hematological and lung cancer and following chemotherapy.

The quality and rate of treatment responses in patients with myelodysplastic syndromes were shown to improve with low doses of Revlimid across two years.

As many of us have experienced, the COVID-19 pandemic affected our lives. But at the beginning, I was receiving treatment for cancer.

The FDA has accepted a new drug application for the intravesical solution of UGN-102 in low-grade intermediate-risk non–muscle-invasive bladder cancer.

Asking physicians how they perform less-invasive surgeries for breast cancer can help reassure patients that their lymphedema risk is kept in mind.

In this on-demand webinar series, CURE partnered with SHARE Cancer Support to learn more about experiences with cancer from two breast cancer survivors.

Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET imaging, an expert explained.

Receiving a cancer diagnosis can be intimidating, but it’s important to remember that it doesn’t mean you have to stop living.

An oral gel to manage oral mucositis — or chemo mouth — may help alleviate the effects of the side effect related to chemotherapy and radiotherapy.

An expert discussed options young patients with breast cancer may have to preserve their fertility before starting cancer treatment.

Patients with gallbladder cancer and cholangiocarcinoma may benefit from receiving Avastin plus Tarceva versus active surveillance.

As part of the CURE® Educated Patient® Prostate Cancer Summit, an expert discussed the role genetic testing plays in treatment decision-making for many.

When I underwent surgery for breast cancer, reconstruction was highly recommended, but I decided to remain flat — a decision I think about sometimes.

An expert discussed the importance of biomarkers in guiding treatment decisions for patients with metastatic breast cancer.